M&A Deal Summary |
|
|---|---|
| Date | 2021-04-01 |
| Target | Ipsen SA - IPN-1087 |
| Sector | Life Science |
| Buyer(s) | Fusion Pharmaceuticals |
| Sellers(s) | Ipsen |
| Deal Type | Divestiture |
SEARCH BY
Fusion Pharmaceuticals is a pharmaceutical company focused on the targeted alpha therapy field. Fusion will exploit its unique expertise in linking medical isotopes to targeting molecules to create highly effective therapeutics. Fusion Pharmaceuticals was formed in 2014 and is based in Hamilton, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: France M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1929 |
| Sector | Life Science |
| Employees | 5,358 |
| Revenue | 3.6B EUR (2024) |
Ipsen is a research and development pharmaceutical company. It manufactures specialty pharmaceuticals and has a worldwide sales presence. Ipsen focuses on products in the gastro-enterology, neurology and cardiovascular therapeutic areas and has also developed specific expertise in some biotech niches such as endocrinology, oncology, neurology and hematology. Ipsen was founded in 1929 and is based in Boulogne-Billancourt, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 2 |
| Country: France M&A | 1 of 2 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-25 |
Clementia Pharmaceuticals
Montreal, Quebec, Canada Clementia Pharmaceuticals, Inc. is a clinical-stage company innovating treatments for people with ultra-rare bone disorders and other diseases with a high medical need. The company is preparing for a 2019 NDA submission to the FDA to seek approval of its lead product candidate, palovarotene, a novel RARγ agonist, for the prevention of heterotopic ossification (HO) associated with flare-up symptoms in adults and children with fibrodysplasia ossificans progressiva (FOP). Clementia Pharmaceuticals was founded in 2010 and is based in Montreal, Quebec. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-11 |
Ipsen - Consumer Healthcare Business
France Ipsen's Consumer Healthcare Business is a clinical specialty focusing on general medicine. It is usually the person’s first point of contact with medical personnel and also includes established brands such as Smecta, Forlax and Tanakan. |
Sell | - |
